Kala Pharmaceuticals Inc
Kala Pharmaceuticals Inc logo
KALA

Kala Pharmaceuticals Inc (KALA)

$4.911.41%

Market is closed
– opens on 8 PM, 07 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$4.6721
Day's Range
$4.97
$4.77
52-Week Range
$97.0
1 month return3.86%
3 month return69.73%
1 year return207.41%
5 year return8.46%

Company Information

Kala is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY® mucus-penetrating particle (MPP) Drug Delivery Technology to two ocular therapies, EYSUVIS™ (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of signs and symptoms of dry eye disease and INVELTYS® (loteprednol etabonate ophthalmic suspension) 1% for the treatment of post-operative inflammation and pain following ocular surgery. The Company also has a pipeline of pre-clinical development programs targeted to address unmet medical needs, including both front and back of the eye diseases.
OrganizationKala Pharmaceuticals Inc
Employees192
CEOMr. Mark T. Iwicki
IndustryHealth Technology

Analyst Recommendation

based on 6 analysts ratings

Buy
66%
Buy
33%
Hold
0%
Sell

Based on 6 Wall street analysts offering stock ratings for Kala Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 847.93%

Current

$4.84

Target

$45.88

Recommendation Trend

Based on 6 analyst

Current1M Ago3M Ago
Buy
4
8
8
Hold
2
2
2
Sell
0
0
1
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
7.6M
Book Value
$12.83
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-2.14
PEG Ratio
0.0
Wall Street Target Price
45.88

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
2.94
Enterprise Value
-2096512
Enterprise Value/Revenue
0.04
Enterprise Value/Ebitda
0.03

Technicals

Beta
0.88
50 Day MA
8.45
200 Day MA
25.53

Institutional Holdings

Vanguard Group Inc

1.91%

Board of Ttees Leland Stanford Jr Univ

0.91%

Samsara BioCapital, LLC

0.79%

Millennium Management LLC

0.75%

Geode Capital Management, LLC

0.59%

Renaissance Technologies Corp

0.47%

Discover more

Frequently Asked Questions

What is Kala Pharmaceuticals Inc share price today?

Can Indians buy Kala Pharmaceuticals Inc shares?

How can I buy Kala Pharmaceuticals Inc shares from India?

Can Fractional shares of Kala Pharmaceuticals Inc be purchased?

What are the documents required to start investing in Kala Pharmaceuticals Inc stocks?

What are today’s High and Low prices of Kala Pharmaceuticals Inc?

What are today’s traded volumes of Kala Pharmaceuticals Inc?

What is today’s market capitalisation of Kala Pharmaceuticals Inc?

What is the 52 Week High and Low Range of Kala Pharmaceuticals Inc?

How much percentage Kala Pharmaceuticals Inc is down from its 52 Week High?

How much percentage Kala Pharmaceuticals Inc is up from its 52 Week low?

What are the historical returns of Kala Pharmaceuticals Inc?

Who is the Chief Executive Officer (CEO) of Kala Pharmaceuticals Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*